Amanote Research
Register
Sign In
Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists
doi 10.1021/jm061094b.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Novel, Orally Bioavailable G-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists
New Insights Into the Stereochemical Requirements of the Bradykinin B1 Receptor Antagonists Binding
Journal of Molecular Graphics and Modelling
Computer Graphics
Theoretical Chemistry
Materials Chemistry
Computer-Aided Design
Spectroscopy
Physical
Bradykinin B1 Receptor (BDKRB1; B1R)
Science-Business eXchange
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders
Potent Nonpeptide Antagonists of the Bradykinin B1 Receptor: Structure-Activity Relationship Studies With Novel Diaminochroman Carboxamides
Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema * Expanded Materials and Methods
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
New Synthetic Antagonists of Bradykinin
British Journal of Pharmacology
Pharmacology
Alkylsulfone-Containing Trisubstituted Cyclohexanes as Potent and Bioavailable Chemokine Receptor 2 (CCR2) Antagonists
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
